Explore All Access
Check if your research matches the topics covered in Antibodies?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Antibodies : Impact Factor & More
eISSN: 2073-4468pISSN: 2073-4468
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Antibodies Key Metrics
Time to Publish 
View Chart Mo
Topics Covered on Antibodies
Monoclonal antibody
Breast cancer
Antibody-drug conjugate
Tumor microenvironment
Inherited epidermolysis bullosa
Effector functions
Severe acute respiratory syndrome coronavirus
Trastuzumab
Polyclonal antibodies
Core protein
Epidermolysis bullosa
Clinical trial
Lymphatic filariasis
Complement system
Complement-dependent cytotoxicity
Pathological Angiogenesis
Spike Protein
Antigen
Drug discovery
Filarial parasite
Antibodies Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
Web of Science
| Overview | |
| Publisher | Multidisciplinary Digital Publishing Institute (MDPI) |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | CHF 1600 |
| Publication Time | 6 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months94%
4 to 6 months6%
7 to 9 months0%
Above 9 months0%
Did you find this useful?
Planning to publish in Antibodies ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Antibodies
A Collection of Single-Domain Antibodies that Crowd Ricin Toxin's Active Site.
- 17 Dec 2018
- Antibodies (Basel, Switzerland)
Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases.
- 23 Jan 2018
- Antibodies (Basel, Switzerland)
Characterization of Monoclonal Antibody-Protein Antigen Complexes Using Small-Angle Scattering and Molecular Modeling.
- 15 Dec 2017
- Antibodies (Basel, Switzerland)
Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops.
- 2 Jun 2017
- Antibodies (Basel, Switzerland)
Antibody Reactivity of B Cells in Lupus Patients with Increased Disease Activity and ARID3a Expression.
- 17 Nov 2015
- Antibodies (Basel, Switzerland)
A Collection of Single-Domain Antibodies that Crowd Ricin Toxin's Active Site.
- 17 Dec 2018
- Antibodies (Basel, Switzerland)
Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases.
- 23 Jan 2018
- Antibodies (Basel, Switzerland)
Characterization of Monoclonal Antibody-Protein Antigen Complexes Using Small-Angle Scattering and Molecular Modeling.
- 15 Dec 2017
- Antibodies (Basel, Switzerland)
Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops.
- 2 Jun 2017
- Antibodies (Basel, Switzerland)
Antibody Reactivity of B Cells in Lupus Patients with Increased Disease Activity and ARID3a Expression.
- 17 Nov 2015
- Antibodies (Basel, Switzerland)
Compare Similar Journals with Antibodies
Select Journals to Compare with Antibodies
Total journals - 9
You can select up to 3 Journals at a time
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
International Journal of Molecular Sciences
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
Molecular Cancer Therapeutics
Publisher: AMER ASSOC CANCER RESEARCH
mAbs
Publisher: TAYLOR & FRANCIS INC
Cancers
Publisher: MDPI
Blood
Publisher: AMER SOC HEMATOLOGY
Immunology
Publisher: WILEY
0 Journals Selected to compare with
Antibodies
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Antibodies
How long has Antibodies been actively publishing? 
Antibodies has been in operation since 2012 till date.
What is the publishing frequency of Antibodies?
Antibodies published with a Quarterly frequency.
How many articles did Antibodies publish last year?
In 2023, Antibodies publsihed undefined articles.
What is the eISSN & pISSN for Antibodies?
For Antibodies, eISSN is 2073-4468 and pISSN is 2073-4468.
Who is the publisher of Antibodies?
Multidisciplinary Digital Publishing Institute (MDPI) is the publisher of Antibodies.
